Introduction {#Sec1}
============

In recent years, *Cytauxzoon felis*, a tick-borne pathogen of felids endemic in North America, is gaining clinical importance. Domestic cats infected with *C. felis* generally develop a peracute and highly fatal disease (Cohn and Birkenheuer [@CR9]).

Furthermore, other closely related piroplasms infecting domestic and wild felids have been reported. *Cytauxzoon manul* was described in naturally infected Pallas's cats (*Otocolobus manul*) from Mongolia (Ketz-Riley et al. [@CR23]; Reichard et al. [@CR38]). In Europe, an unnamed species of *Cytauxzoon* was reported not only in domestic cats from Spain (Criado-Fornelio et al. [@CR11]; Díaz-Regañón et al. [@CR13]), France (Criado-Fornelio et al. [@CR12]; Legroux et al. [@CR25]), Italy (Carli et al. [@CR6], [@CR7]), Portugal (Alho et al. [@CR1]) and Switzerland (Nentwig et al. [@CR33]) but also in wild cats (*Felis silvestris*) in Spain (Barandika et al. [@CR3]; León et al. [@CR26]), Romania (Gallusová et al. [@CR15]), Italy (Veronesi et al. [@CR43]) and Bosnia and Herzegovina (Hodžić et al. [@CR18]), Iberian lynx (*Lynx pardinus*) in Spain (Luaces et al. [@CR28]; Millán et al. [@CR31], [@CR32]; Meli et al. [@CR30]; García-Bocanegra et al. [@CR16]) and Eurasian lynx (*Lynx lynx*) in Romania (Gallusová et al. [@CR15]). Studies on *Cytauxzoon* sp. in Europe show different infection rates depending on countries and host species involved. While the infection rate in domestic cats is ranging from 0.8% in France (Criado-Fornelio et al. [@CR12]) to 23% in Italy (Carli et al. [@CR6]), in wild felids, the assessed prevalence is generally higher than 50% in Romania (Gallusová et al. [@CR15]), Bosnia and Herzegovina (Hodžić et al. [@CR18]) and Spain (Barandika et al. [@CR3]; León et al. [@CR26]).

The European isolates of *Cytauxzoon* seem to be less virulent than *C. felis*, and the clinical manifestations appear to be associated with immune-mediated diseases or secondary infections (Díaz-Regañón et al. [@CR13]; Nentwig et al. [@CR33]). However, reports of *Cytauxzoon* sp. infections in Europe are scarce and most of them refer to subclinical cases. Non-specific clinical signs such as lethargy, anorexia, anaemia, fever, weight loss, tachycardia, tachypnoea, diarrhoea and vomiting have also been described (Carli et al. [@CR6], [@CR7]; Alho et al. [@CR1]; Legroux et al. [@CR25]).

The present paper reports the first molecular confirmation of *Cytauxzoon* sp. infection in Germany and provides a detailed clinical picture of the disease in association with feline immunodeficiency virus (FIV) infection.

Methods {#Sec2}
=======

Case report {#Sec3}
-----------

In March 2017, a 6-year-old male domestic cat was referred to a veterinary facility in Saarlouis (49.31° N, 6.75° E), a small city located in Saarland (south-western Germany), with anorexia and lethargy. The cat had an outdoor lifestyle and had never travelled abroad. According to the owner, the patient had refused to eat in the last 3 days and lost approximately 1.5 kg in the previous few weeks. Episodes of vomiting could not be excluded due to the outdoor lifestyle of the cat. The patient received supportive therapy for 5 days with maropitant citrate (Cerenia®, 1 mg/kg, SC), metamizole (Novalgin®; 35 mg/kg, IM), amoxicillin (Betamox® long acting 150 mg/ml, 15 mg/kg, SC) and fluids (Lactated Ringer's solution, 15 ml/kg, SC). Despite the therapy, the cat was euthanized on the 5th day, due to the worsening of the clinical state, being presented in a lateral decubitus with severe lethargy and ataxia. Nevertheless, the owner elected against necropsy. No information regarding the history of tick infestation or previous antiparasitic treatments was available.

Clinical blood analyses {#Sec4}
-----------------------

In March 2017, a complete blood count and serum clinical biochemical analysis (including the assessment of liver, kidney and pancreatic parameters) were performed at IDEXX reference laboratory in Ludwigsburg, Germany (Table [1](#Tab1){ref-type="table"}). Symmetric dimethylarginine (SDMA) was measured using a commercially available high-throughput immunoassay (IDEXX SDMA Test, IDEXX Laboratories Inc.; Ernst et al. [@CR14]). No urine examination was performed.Table 1Clinico-pathological values at March 2017 and January 2016, compared with reference values; for clinical chemistry, only abnormal values were includedParameterMeasured value (unit) in 2016Measured value (unit) in 2017Reference interval (unit)Urea nitrogen26 mg/dl**69 mg/dl**16--38 (mg/dl)Creatinine0.9 mg/dl**2.8 mg/dl**\< 1.9 (mg/dl)Phosphate1.5 mmol/l**2.4 mmol/l**0.8--2.2 (mmol/l)SDMA4 μg/dl**45 μg/dl**≤ 14 (μg/dl)Albumin4.4 g/dl**1.8 g/dl**2.7--4.4 (g/dl)Albumin-globulin ratio1.52**0.35**\> 0.57Alkaline phosphatase77 U/l**162 U/l**\< 73 (U/I)Erythrocytes10.1 T/l**6.5 T/l**7.1--11.5 (T/I)Haemoglobin13.4 g/dl**8.9 g/dl**10.3--16.2 (g/dl)Haematocrit4329.228.2--52.7%MCV4344.939--56 (fl)MCH1313.712.6--16.5 (pg/cell)MCHC3130.628.5--37.8 (g/dl)Thrombocytes275186155--641 (G/l)Reticulocytes**37,000/μl15,000/μl**≥ 50,000/μl (when anaemic)Leukocytes8.218.23.9--19 (G/l)Neutrophils6231/μl**16,781/μl**2620--15,170/μlLymphocytes1575912850--5850/μlMonocytes320/μl**547/μl**40--530/μlAbnormal results are set in bold

Approximately 1 year prior to these investigations (January 2016), a blood sample from the same patient was sent to IDEXX laboratories for similar haematologic and clinical biochemical analysis (Table [1](#Tab1){ref-type="table"}). At that time, the blood sample was also tested for feline leukaemia virus (FeLV) antigen (p27; PetChek FeLV, IDEXX Laboratories Inc.), as well as for antibodies against FIV (p24/gp40; PetChek Plus Anti-FIV, IDEXX Laboratories Inc.) and feline coronavirus (FCoV) (FCoV ELISA cat, Afosa, Germany).

Microscopic examination of blood smears {#Sec5}
---------------------------------------

In March 2017, May-Grünwald-Giemsa-stained blood smears were prepared from peripheral blood and were evaluated for the presence of blood pathogens. The degree of parasitaemia was estimated by counting the number of infected erythrocytes per 2000 erythrocytes with an Olympus BX61 microscope at × 1000 magnification. The measurement of the well-defined organisms (with a characteristic shape, *n* = 100) was assessed with a DP72 camera and Cell\^F software (Olympus Corporation, Japan).

Molecular analyses and DNA sequencing {#Sec6}
-------------------------------------

Total nucleic acids were extracted using the QIAamp DNA Blood BioRobot MDx kit (Qiagen, Hilden, Germany) following the manufacturer's instructions. A polymerase chain reaction (PCR) assay for Piroplasmida targeting the 18S rRNA gene was performed according to Carret et al. ([@CR8]) and Katargina et al. ([@CR22]). Furthermore, a nested and a conventional PCR protocol were used for the amplification of a part of the 18S rRNA gene of the phylum Apicomplexa using primer pairs BTH-1F/BTH-1R, GF2/GR2 and 7549/7548, respectively, following previously published reaction procedures and protocols (Reichard et al. [@CR38]; Hrazdilová et al. [@CR20]). PCR products were visualized by electrophoresis in a 2% agarose gel. After purification, the amplicons were submitted for sequencing on both strands (Macrogen, the Netherlands). Consensus sequences were compared with sequences available in GenBank™ dataset by Basic Local Alignment Search Tool (BLAST) analysis.

Results {#Sec7}
=======

Haematology and blood biochemistry {#Sec8}
----------------------------------

In March 2017, the haematological analyses revealed azotaemia with markedly increased SDMA, hypercreatinemia, as well as hyperphosphatemia and hypoalbuminemia. Furthermore, a mild non-regenerative anaemia was present. Abnormal laboratory findings are shown in Table [1](#Tab1){ref-type="table"}. The results indicated decreased glomerular filtration rate that suggested the presence of kidney disease. Urinalysis was not performed to assess specific gravity, protein concentration or sediment.

In January 2016, the haematological and clinical chemistry variables had been within normal limits. FeLV and FCoV tests were negative, but a positive FIV antibody test was obtained.

Blood smear microscopy {#Sec9}
----------------------

Blood smear examination in March 2017 revealed morphologically inconspicuous leukocytes, and erythrocytes displayed no significant anisocytosis or polychromasia. Blood smear evaluation revealed round to oval signet ring--shaped organisms inside the erythrocytes, with a light blue cytoplasm and a blue nucleus usually located in an eccentric position (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1May-Grünwald-Giemsa stained peripheral blood smear (× 1000). *Cytauxzoon* sp. appears as single or paired signet ring--shaped organisms (arrows) within erythrocytes. A high parasitaemia can be observed

One to four merozoites were observed within individual red blood cells. The mean length of the well-defined forms was 1.2 ± 0.2 μm, and the measured width was 1.0 ± 0.2 μm. The intensity of parasitaemia was estimated at 33.0%. The intracellular parasites were morphologically suggestive for a piroplasm. Moreover, the typical signet ring--shaped organisms could be clearly differentiated from feline haemotropic mycoplasma due to their evident large nuclear area (Cohn and Birkenheuer [@CR9]).

Microscopic examination of a blood smear in January 2016 had revealed no blood cell morphologic abnormalities and no microorganisms.

Molecular detection and characterization {#Sec10}
----------------------------------------

The presence of *Cytauxzoon* sp. DNA was confirmed by positive PCR results in all three protocols and subsequent sequencing. The longest consensus sequence available (1010 bp) was submitted to GenBank™ under the accession number *MN629916*. BLAST analysis of the sequenced 18S rRNA gene region revealed 99.9% nucleotide sequence identity with a GenBank™ sequence of *Cytauxzoon* sp. originating from a domestic cat from France (accession number EU622908). Moreover, similarities of 100% were observed with sequences of *Cytauxzoon* sp. ([MF503141](https://www.ncbi.nlm.nih.gov/nucleotide/MF503143.1?report=genbank&log$=nucltop&blast_rank=8&RID=SSXE1UNF015), [MF503143](https://www.ncbi.nlm.nih.gov/nucleotide/MF503143.1?report=genbank&log$=nucltop&blast_rank=8&RID=SSXE1UNF015)-6, KU306941-3, KU306945-8; KX881967) obtained from pet cats from Switzerland and France with clinical cytauxzoonosis (Legroux et al. [@CR25]; Nentwig et al. [@CR33]).

Discussion {#Sec11}
==========

The study reported herein describes the clinical picture, laboratory findings and diagnostic procedures of a *Cytauxzoon* sp. clinical infection in a domestic cat from Germany. A previous piroplasmid fatal infection was described in a captive Bengal tiger from a zoo in Germany, when parasitic inclusions resembling *Cytauxzoon* spp. were visualized in histological sections of various tissues, the largest number being found in blood vessels of lymph nodes and spleen. Even though there was no evidence of tick infestation of the tiger, three bobcats (*Lynx rufus*) originating from an American zoo were incriminated as a possible source of the infection (Jakob and Wesemeier [@CR21]).

The cat patient in the current report was also diagnosed with a FIV infection, being presented in a critical condition a few days following clinical examination due to suspected kidney disease. Since clinical cases of canine babesiosis and theilerioses are associated with acute or chronic nephropathy or glomerulonephritis (Camacho-García [@CR5]; Solano-Gallego et al. [@CR41]), the renal disturbances observed in this patient could have been attributed to the piroplasmid infection to FIV or both. Moreover, in *C. felis* infection, several cases of concomitant kidney disorders have been described in domestic and wild felids (Meier and Moore [@CR29]; Peixoto et al. [@CR34]; Lewis et al. [@CR27]). Previous studies have also confirmed that FIV infection can induce the accumulation of immune complexes in renal tissue; therefore, a causative relationship between FIV infection and glomerulonephritis has been posited (Reinacher and Frese [@CR39]; Poli et al. [@CR36]; Harley and Langston [@CR17]; Hosie et al. [@CR19]). In the light of this information and the laboratory results (hypoalbuminemia pointing toward a renal loss of protein, increased creatinine and phosphate values as well as a very high SDMA value), one could postulate that the patient had glomerular disease due to immune-complex deposition in terms of a membranoproliferative glomerulonephritis. Other potential causes of hypalbuminaemia in this patient would include decreased production, other causes of loss (i.e. blood loss and protein-losing enteropathy) or haemodilution. In cases of renal injury, SDMA serum concentration increases earlier than creatinine, remaining elevated also in cases of chronic kidney disease (on average with 40% reduction of glomerular filtration rate, compared with up to 75% reduction needed to increase the creatinine value) (Relford et al. [@CR40]).

Regarding the pathogenesis of FIV infection, cats remain subclinically infected for several years until functional immunodeficiency (by increasing the susceptibility to secondary infections and neoplasia) and/or immune-mediated diseases will eventually translate into clinical manifestation around 4 to 6 years of age or older (Hosie et al. [@CR19]). In the present case, the cat did not display any noticeable clinical signs at 5 years of age, approximately 1 year before merozoites resembling *Cytauxzoon* sp. were detected in high numbers in the blood smear. Therefore, it can be presumed that, as a result of immunosuppression caused by FIV, the piroplasm contributed as an opportunistic factor triggering the clinical picture. Furthermore, an increased pathogenicity in association with immunosuppression induced by concurrent diseases has been previously suggested in *Cytauxzoon* sp. infection (Carli et al. [@CR6]; Díaz-Regañón et al. [@CR13]). However, the clinical role of *Cytauxzoon* sp. in domestic cats without immunosuppression and coinfections remains debatable, as the information about pathogenesis and clinical involvement is limited. Although some cases of clinical illness and fatal outcome have been described (Alho et al. [@CR1]; Legroux et al. [@CR25]; Nentwig et al. [@CR33]), the majority of *Cytauxzoon* sp. infected cats were apparently healthy, with only few animals showing mild anaemia (Carli et al. [@CR6], [@CR7]; Díaz-Regañón et al. [@CR13]; Nentwig et al. [@CR33]).

Microscopic examination of the blood smear revealed a degree of parasitaemia of 33%. Other clinical studies showed lower levels of parasitaemia (Luaces et al. [@CR28]; Carli et al. [@CR6], [@CR7]; Legroux et al. [@CR25]), while similar percentages of piroplasm-infected erythrocytes were observed in the blood smear of three cats with cytauxzoonosis from Switzerland (Nentwig et al. [@CR33]).

As the molecular confirmation of *Cytauxzoon* sp. infection was established post-mortem, no specific anti-piroplasm treatment was applied. Although, in *C. felis* infection, the recommended therapeutic protocol consists of atovaquone and azithromycin (Cohn et al. [@CR10]), the optimal therapy for *Cytauxzoon* sp. infection remains unknown due to the lack of controlled clinical studies. In a recently published case report, three 2-month-old kittens infected with *Cytauxzoon* sp. were treated with a combination of atovaquone and azithromycin, with a putative success (Nentwig et al. [@CR33]). Also, previously published *Cytauxzoon* sp. infections in domestic cats have been medicated with various antiprotozoal drugs, including imidocarb dipropionate and doxycycline (Carli et al. [@CR6], [@CR7]; Alho et al. [@CR1]; Legroux et al. [@CR25]). Clinical studies in Europe reported that a single imidocarb dipropionate administration was not successful in treating cytauxzoonosis, although the addition of doxycycline cleared parasitaemia in another patient (Carli et al. [@CR7]; Legroux et al. [@CR25]).

Based on the sequencing results performed on the 18S rRNA gene amplification product, *Cytauxzoon* sp. detected in the present case revealed a high homology (99--100%) with *Cytauxzoon* sp. reported in European domestic felids (Legroux et al. [@CR25]; Nentwig et al. [@CR33]) and with *Cytauxzoon manul* (99.8%) described from Pallas's cats from Mongolia (Reichard et al. [@CR38]). In contrast, the sequence displayed a more distant identity of 95% to *C. felis* 18S rRNA partial sequences deposited in GenBank®.

A significant association between the detection of *Cytauxzoon* sp. DNA in European domestic cats and outdoor lifestyle has been reported, particularly in rural areas (Carli et al. [@CR6]; Díaz-Regañón et al. [@CR13]). In agreement with these reports, the cat from the present study showed an outdoor lifestyle, which entails a higher risk of infection due to exposure to tick vectors and wildlife reservoirs. For *C. felis* infections of domestic cats, the American bobcat (*L. rufus*) is assumed to act as the main reservoir (Kier et al. [@CR24]) and *Amblyomma americanum* and *Dermacentor variabilis* are the confirmed tick vectors (Blouin et al. [@CR4]; Reichard et al. [@CR37]). However, for the European isolates of *Cytauxzoon* sp., little is known about vectors and routes of transmission. In Europe, high prevalences of *Cytauxzoon* sp. infection were found in *Felis silvestris* in Romania (Gallusová et al. [@CR15]), Italy (Veronesi et al. [@CR43]), Bosnia and Herzegovina (Hodžić et al. [@CR18]) and Spain (Barandika et al. [@CR3]; León et al. [@CR26]). Moreover, Germany has one of the biggest European populations of *F. silvestris,* which is concentrated in the low altitude mountain areas (Balzer et al. [@CR2]). Studies on wild animal distribution suggest that Saarlouis city is surrounded by an abundant wild cat population (Steyer et al. [@CR42]). Consequently, considering that they might live in close proximity to urban and rural areas and crossbreed with domestic cats, it is possible that wild cats play a central role in the transmission of *Cytauxzoon* sp. in West Germany as well as in other European countries. *Ixodes ricinus* is the most commonly found tick in Germany (Petney et al. [@CR35]), and it has been hypothesised to be a possible vector for *Cytauxzoon* sp. (Gallusová et al. [@CR15]).

This study describes, to the best of our knowledge, the first case of molecularly confirmed *Cytauxzoon* sp. infection in Germany.

Conclusions {#Sec12}
===========

This case provides a new geographical record of *Cytauxzoon* sp. infection in domestic cats in Central Europe and describes the clinical and laboratory findings in association with FIV infection. Results advocate that cytauxzoonosis should be considered as a differential diagnosis in cases of anaemia in domestic cats with an outdoor lifestyle, particularly in areas where populations of wild felids are present. Additional studies are required to identify the possible arthropod vectors which may be involved in the transmission and to clarify the relationship between *Cytauxzoon* sp. infection in cats and the presented clinical signs.
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